Pharmaceutical company Eli Lilly on Wednesday said that its combination of two antibody drugs to fight the coronavirus cuts the risk of hospitalization and death by 87 percent. The finding is based on a study of 769 high-risk COVID-19 patients aged 12 and older with mild to moderate COVID-19. The company said that no patients who...
source https://nypost.com/2021/03/10/eli-lilly-covid-drug-combo-cuts-death-hospitalizations-by-87/
0 Comments